Immunitybio Stock Investor Sentiment
| IBRX Stock | USD 4.64 0.16 3.33% |
Slightly above 63% of all Immunitybio's investors are looking to take a long position. The analysis of the overall investor sentiment regarding Immunitybio suggests that some traders are interested. Immunitybio's investing sentiment can be driven by a variety of factors including economic data, Immunitybio's earnings reports, geopolitical events, and overall market trends.
Immunitybio |
Immunitybio Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Immunitybio can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Immunitybio that are available to investors today. That information is available publicly through Immunitybio media outlets and privately through word of mouth or via Immunitybio internal channels. However, regardless of the origin, that massive amount of Immunitybio data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Immunitybio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Immunitybio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Immunitybio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Immunitybio alpha.
Immunitybio Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Acquisition by Blaszyk Michael D of 77633 shares of Immunitybio at 5.96 subject to Rule 16b-3 | 09/30/2024 |
2 | 800 percent Upside For This Biotech Stock - Analyst Initiates Coverage On Bladder Cancer Focused ImmunityBio | 10/23/2024 |
3 | First Patients Dosed in Phase 1 Clinical Study of ImmunityBios CAR-NK Cell Therapy for the Treatment of Relapsed B-Cell Non-Hodgkin Lymphoma | 10/24/2024 |
4 | ImmunityBio Shares Gap Up Whats Next | 10/25/2024 |
5 | PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday | 10/28/2024 |
6 | 2 Stocks to Watch After New Analyst Coverage | 11/01/2024 |
7 | Y-mAbs Therapeutics, Inc. Reports Q3 Loss, Lags Revenue Estimates | 11/08/2024 |
8 | ImmunityBio Inc Q3 2024 Earnings GAAP EPS of -0.12, Revenue Surges to 6. ... | 11/13/2024 |
9 | ImmunityBio Completes ANKTIVAs Post-Approval Enrollment of the 100th Patient in BCG Unresponsive NMIBC CIS Trial and Reports a Complete Response Rate of 71 perc... | 11/19/2024 |
10 | ImmunityBio Stock Price Down 3.9 percent Heres What Happened | 11/22/2024 |
11 | ImmunityBio Inc Announces Public Offering of Common Stock | 12/10/2024 |
Additional Tools for Immunitybio Stock Analysis
When running Immunitybio's price analysis, check to measure Immunitybio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunitybio is operating at the current time. Most of Immunitybio's value examination focuses on studying past and present price action to predict the probability of Immunitybio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunitybio's price. Additionally, you may evaluate how the addition of Immunitybio to your portfolios can decrease your overall portfolio volatility.